1. Microplastics in the Human Body: Exposure, Detection, and Risk of Carcinogenesis: A State-of-the-Art Review.
- Author
-
Dzierżyński, Eliasz, Gawlik, Piotr J., Puźniak, Damian, Flieger, Wojciech, Jóźwik, Katarzyna, Teresiński, Grzegorz, Forma, Alicja, Wdowiak, Paulina, Baj, Jacek, and Flieger, Jolanta
- Subjects
RISK assessment ,EARLY detection of cancer ,CELLULAR signal transduction ,POLLUTION ,ENVIRONMENTAL exposure ,MICROPLASTICS ,CARCINOGENESIS ,INFLAMMATION - Abstract
Simple Summary: Environmental pollution caused by nano- and microplastics (MPs) is widespread and has become a global issue. There is a confirmed accumulation of MPs in animal and human tissues, raising concerns about potential health effects. The accumulation of NMPs in human tissues, as well as their genotoxicity, mutagenicity, and impact on cancer development, is a relatively new area of research that presents several challenges, mainly related to instrumental limitations and ensuring quality assurance and quality control (QA/QC) in studies of both exposure and subsequent fate in the body, such as translocation and possible accumulation. Background: Humans cannot avoid plastic exposure due to its ubiquitous presence in the natural environment. The waste generated is poorly biodegradable and exists in the form of MPs, which can enter the human body primarily through the digestive tract, respiratory tract, or damaged skin and accumulate in various tissues by crossing biological membrane barriers. There is an increasing amount of research on the health effects of MPs. Most literature reports focus on the impact of plastics on the respiratory, digestive, reproductive, hormonal, nervous, and immune systems, as well as the metabolic effects of MPs accumulation leading to epidemics of obesity, diabetes, hypertension, and non-alcoholic fatty liver disease. MPs, as xenobiotics, undergo ADMET processes in the body, i.e., absorption, distribution, metabolism, and excretion, which are not fully understood. Of particular concern are the carcinogenic chemicals added to plastics during manufacturing or adsorbed from the environment, such as chlorinated paraffins, phthalates, phenols, and bisphenols, which can be released when absorbed by the body. The continuous increase in NMP exposure has accelerated during the SARS-CoV-2 pandemic when there was a need to use single-use plastic products in daily life. Therefore, there is an urgent need to diagnose problems related to the health effects of MP exposure and detection. Methods: We collected eligible publications mainly from PubMed published between 2017 and 2024. Results: In this review, we summarize the current knowledge on potential sources and routes of exposure, translocation pathways, identification methods, and carcinogenic potential confirmed by in vitro and in vivo studies. Additionally, we discuss the limitations of studies such as contamination during sample preparation and instrumental limitations constraints affecting imaging quality and MPs detection sensitivity. Conclusions: The assessment of MP content in samples should be performed according to the appropriate procedure and analytical technique to ensure Quality and Control (QA/QC). It was confirmed that MPs can be absorbed and accumulated in distant tissues, leading to an inflammatory response and initiation of signaling pathways responsible for malignant transformation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF